Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q96C12
UPID:
ARMC5_HUMAN
Alternative names:
-
Alternative UPACC:
Q96C12; Q86WM9; Q9H7P8; Q9H925
Background:
Armadillo repeat-containing protein 5 plays a pivotal role in various physiological processes, including fetal development, T-cell function, and adrenal gland growth homeostasis. It is known for its negative regulation of adrenal cells survival and significant involvement in steroidogenesis, influencing steroidogenic enzymes expression and cortisol production.
Therapeutic significance:
The protein's link to ACTH-independent macronodular adrenal hyperplasia 2, a condition leading to excessive cortisol production and Cushing syndrome, underscores its therapeutic potential. Targeting this protein could lead to innovative treatments for disorders related to cortisol imbalance.